Exhibit-10.12

AMENDMENT TO FINANCIAL PRODUCTS LICENSE AGREEMENT

This Amendment is entered into as of October 16, 2026, by and between CF Benchmarks Ltd (“Licensor”), Bitwise

Investment Advisers, LLC, (“BIA”) and Bitwise Investment Manager, LLC (“BIM”) (each, a “Licensee” and

together, the “Licensees”).

The Licensor and BIM entered into a Financial Product License Agreement on July 12th, 2023, as amended by the

Variation Agreement on May 1st, 2024, October 27th, 2025 and December 12, 2025 (the “Original Agreement”).

The Licensor and Licensees, through this amendment agreement (the “Amendment Agreement”), wish to amend the

Original Agreement by adding BIA as a third counterparty and by incorporating the changes set out below.

The amendments and additions contained herein shall have effect from October 15, 2026 onwards, and shall

supersede, where applicable, provisions contained in the Original Agreement.

Except as expressly amended by this Amendment, all terms and conditions of the Original Agreement shall remain

unchanged and in full force and effect. This Amendment shall be read and construed as one with the Original

Agreement, and, in the event of any conflict, the terms of this Amendment shall prevail with respect to the subject

matter herein.

The terms of the Original Agreement shall be deemed amended to reflect both the express changes set forth in this

Amendment Agreement and any other modifications that are reasonably necessary to give full effect to such changes.

Except to the extent inconsistent with this Amendment Agreement or the changes effected hereby, all other terms,

conditions, rights, and obligations of the Original Agreement shall remain unchanged and in full force and effect. This

Amendment Agreement and the Original Agreement shall be read and construed together as a single contract.

Licensor and Licensee are sometimes referred to herein collectively as the “Parties” and individually as a “Party”

WITNESSETH:

WHEREAS, the Licensees wishes to license additional indices from Licensor for use in connection with certain

financial products; and

WHEREAS, the Parties desire to amend Schedule 1 and Schedule 2 inclusive, of the Original Agreement.

REPLACEMENT OF SCHEDULE 1

The Parties agree to amend and replace the existing SCHEDULE 1 of the Original Agreement in its entirety

with the below.

SCHEDULE 1

Asset Pair

License Grant

Date

Indices

Bitcoin - US Dollar

January 11th 2024

CME CF Bitcoin Real Time Index (BRTI)

CME CF Bitcoin Reference Rate (BRR)

CME CF Bitcoin Reference Rate - New York Variant (BRRNY)

CME CF Bitcoin Reference Rate – APAC Variant (BRRAP)

Ether -US Dollar

July 23rd 2024

CME CF Ether - Dollar Real Time Index (ETHUSD_RTI)

CME CF Ether - Dollar Reference Rate (ETHUSD_RR)

CME CF Ether - Dollar Reference Rate - New York Variant

(ETHUSD_NY)

 


Exhibit-10.12

 


Exhibit-10.12

 

 

CME CF Ether – Dollar Reference Rate – APAC Variant

(ETHUSD_AP)

Solana - US Dollar

The date at which

Product Number 4

is admitted for

trading on a

National Stock

Exchange

CME CF Solana - Dollar Real Time Index (SOLUSD_RTI)

CME CF Solana - Dollar Reference Rate (SOLUSD_RR)

CME CF Solana - Dollar Reference Rate - New York Variant

(SOLUSD_NY)

CME CF Solana – Dollar Reference Rate – APAC Variant

(SOLUSD_AP)

Chainlink - US Dollar

The date at which

Product Number 5

is admitted for

trading on a

National Stock

Exchange

CME CF Chainlink - Dollar Real Time Index (LINKUSD_RTI)

CME CF Chainlink - Dollar Reference Rate (LINKUSD_RR)

CME CF Chainlink - Dollar Reference Rate - New York Variant

(LINKUSD_NY)

CME CF Chainlink – Dollar Reference Rate – APAC Variant

(LINKUSD_AP)

DOGE - US Dollar

The date at which

Product Number 6

is admitted for

trading on a

National Stock

Exchange

CF DOGE - Dollar Real Time Index (DOGEUSD_RTI)

CF DOGE - Dollar Reference Rate (DOGEUSD_RR)

CF DOGE - Dollar Reference Rate - New York Variant

(DOGEUSD_NY)

CF DOGE – Dollar Reference Rate – APAC Variant

(DOGEUSD_AP)

Avalanche - US Dollar

The date at which

Product Number 7

is admitted for

trading on a

National Stock

Exchange

CME CF Avalanche - Dollar Real Time Index

(AVAXUSD_RTI)

CME CF Avalanche - Dollar Reference Rate (AVAXUSD_RR)

CME CF Avalanche - Dollar Reference Rate - New York

Variant (AVAXUSD_NY)

CME CF Avalanche – Dollar Reference Rate – APAC Variant

(AVAXUSD_AP)

XRP - US Dollar

The date at which

Product Number 8

is admitted for

trading on a

National Stock

Exchange

CME CF XRP - Dollar Real Time Index (XRPUSD_RTI)

CME CF XRP - Dollar Reference Rate (XRPUSD_RR)

CME CF XRP - Dollar Reference Rate - New York Variant

(XRPUSD_NY)

CME CF XRP – Dollar Reference Rate – APAC Variant

(XRPUSD_AP)

 


Exhibit-10.12

HYPE - US Dollar

The date at which

CF HYPE - Dollar Real Time Index (HYPEUSD_RTI)

 


Exhibit-10.12

 

Product Number 9

is admitted for

trading on a

National Stock

Exchange

CF HYPE - Dollar Reference Rate - New York Variant

(HYPEUSD_NY)

CF HYPE - Dollar Reference Rate (HYPEUSD_RR)

CF HYPE - Dollar Reference Rate - APAC Variant

(HYPEUSD_AP)

NEAR – US Dollar

The date at which

Product Number

10 is admitted for

trading on a

National Stock

Exchange

CME CF NEAR – Dollar Real Time Index (NEARUSD_RTI)

CME CF NEAR Protocol-Dollar Reference Rate – New York

Variant (NEARUSD_NY)

CME CF NEAR Protocol-Dollar Reference Rate

(NEARUSD_RR)

ZEC - US Dollar

The date at which

Product Number

11 is admitted for

trading on a

National Stock

Exchange

CF ZEC - Dollar Real Time Index (ZECUSD_RTI)

CF ZEC - Dollar Reference Rate - New York Variant

(ZECUSD_NY)

CF ZEC - Dollar Reference Rate (ZECUSD_RR)

CF ZEC - Dollar Reference Rate - APAC Variant

(ZECUSD_AP)

In addition to the above indices, CF Benchmarks will also provide the Free Float Supply of each base asset

listed in the above table, which the Licensees may utilise for the defined use cases in connection with the

Products listed in Schedule 2.

 


Exhibit-10.12

REPLACEMENT OF SCHEDULE 2

The Parties further agree to amend and replace the existing SCHEDULE 2 of the Original Agreement in its

entirety with the below SCHEDULE 2.

SCHEDULE 2 – SPECIFIED PRODUCTS & USES CASES

Number

FINANCIAL

PRODUCTS

USE CASES

1

The Bitwise Bitcoin

ETF (BITB) an

Exchange Traded

Fund to admitted

for trading on

CBOE BZX and/or

other National

Stock Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

2

The Bitwise

Ethereum ETF

(ETHW), Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

3

The Bitwise Bitcoin

& Ethereum ETF,

Exchange Traded

Fund to admitted

for trading on

CBOE BZX and/or

other National

Stock Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

 

 


Exhibit-10.12

4

The Bitwise Solana

ETF, Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

5

The Bitwise

Chainlink ETF,

Exchange Traded

Fund to admitted

for trading on

CBOE BZX and/or

other National

Stock Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

6

The Bitwise DOGE

ETF, Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

 

 


Exhibit-10.12

7

The Bitwise

Avalanche ETF,

Exchange Traded

Fund to admitted

for trading on

CBOE BZX and/or

other National

Stock Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

8

The Bitwise XRP

ETF, Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

9

The Bitwise HYPE

ETF, Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

 

 


Exhibit-10.12

10

The Bitwise NEAR

ETF, Exchange Traded

Fund to admitted for

trading on CBOE BZX

and/or other National

Stock Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

11

The Bitwise ZEC

ETF, Exchange

Traded Fund to

admitted for trading

on CBOE BZX

and/or other

National Stock

Exchanges

● The calculation of Net Asset Value (NAV) or Indicative Net Asset Value

(I-NAV) for the Product in the course of administering, reporting and

marketing the Product

● The determination of the Product AuM in the course of administering,

reporting and marketing the Product

● The dissemination of the Product NAV, I-NAV and AuM in the Product

that have been calculated using the Index Data

● Comparing the Index Data to data associated with the Nominated Product

in its Informational Materials, such as performance, returns, volatility,

drawdown, Sharpe ratio and other commonly used financial and

investment metrics

● Utilisation of Free Float Data as listed in Schedule 1 in order to determine

the weights of each base asset within the Product

 

 


Exhibit-10.12

Signed by Johanna Collins-Wood for and on behalf of BITWISE

INVESTMENT MANAGER, LLC

By: /s/ Johanna Collins-Wood

Authorised Signatory

 

 

Signed by Sui Chung for and on behalf of CF BENCHMARKS LTD

By: /s/ Sui Chung

Director